Long-term safety of recombinant growth hormone

被引:1
|
作者
Carel, J.-C.
Coste, J.
机构
[1] Hop Robert Debre, APHP, Serv Endocrinol Diabetol Pediat, F-75935 Paris 19, France
[2] Hop Robert Debre, APHP, Inserm U690, F-75935 Paris, France
来源
ARCHIVES DE PEDIATRIE | 2007年 / 14卷 / 06期
关键词
growth hormone; cancer; tolerance; adverse effects;
D O I
10.1016/j.arcped.2007.04.004
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:615 / 617
页数:3
相关论文
共 50 条
  • [41] Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome
    Wolfgram, Peter M.
    Carrel, Aaron L.
    Allen, David B.
    [J]. CURRENT OPINION IN PEDIATRICS, 2013, 25 (04) : 509 - 514
  • [42] Metabolic Health and Long-Term Safety of Growth Hormone Treatment in Silver-Russell Syndrome
    Smeets, Carolina C. J.
    Renes, Judith S.
    van der Steen, Manouk
    Hokken-Koelega, Anita C. S.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (03): : 983 - 991
  • [43] Long-term safety of growth hormone replacement therapy in survivors of cancer and tumors of the pituitary region
    Bolier, Melissa
    van der Lelij, Aart-Jan
    Janssens, Geert O.
    van den Heuvel-eibrink, Marry M.
    Neggers, Sebastian J. C. M. M.
    [J]. ENDOCRINE-RELATED CANCER, 2023, 30 (07)
  • [44] Long-term growth hormone therapy in mitochondrial cytopathy
    Barberi, S
    Bozzola, E
    Berardinelli, A
    Meazza, C
    Bozzola, M
    [J]. HORMONE RESEARCH, 2004, 62 (02) : 103 - 106
  • [45] Design of the long-term observational cohort study with recombinant human growth hormone in Korean children: LG Growth Study
    Chung, Sochung
    Yoo, Jae-Ho
    Choi, Jin Ho
    Rhie, Young-Jun
    Chae, Hyun-Wook
    Kim, Jae Hyun
    Hwang, Il Tae
    Shin, Choong Ho
    Kim, Eun Young
    Lee, Kee-Hyoung
    [J]. ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2018, 23 (01) : 43 - 50
  • [46] Final height after long-term treatment with recombinant human growth hormone (RHGH) in children with uremic growth failure
    Nissel, Richard
    Ucur, Esat
    Mehls, Otto
    Haffner, Dieter
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 367 - 368
  • [47] Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism
    Watts, Nelson B.
    Bilezikian, John P.
    Bone, Henry G.
    Clarke, Bart L.
    Denham, Douglas
    Levine, Michael A.
    Mannstadt, Michael
    Peacock, Munro
    Rothman, Jeffrey G.
    Vokes, Tamara J.
    Warren, Mark L.
    Yin, Shaoming
    Sherry, Nicole
    Shoback, Dolores M.
    [J]. JOURNAL OF THE ENDOCRINE SOCIETY, 2023, 7 (05)
  • [48] LONG-TERM GROWTH-HORMONE TREATMENT IN GROWTH-HORMONE DEFICIENT ADULTS
    JORGENSEN, JOL
    PEDERSEN, SA
    THUESEN, L
    JORGENSEN, J
    MOLLER, J
    MULLER, J
    SKAKKEBAEK, NE
    CHRISTIANSEN, JS
    [J]. ACTA ENDOCRINOLOGICA, 1991, 125 (05): : 449 - 453
  • [49] Long-term safety and effectiveness of recombinant human growth Hormone in Korean pediatric patients with growth disorders: 7-year interim analysis from LG Growth Study
    Lee, Young Ah
    Chung, Sochung
    Rhie, Young-Jun
    Kim, Jae Hyun
    Chae, Hyun-Wook
    Yoo, Jae-Ho
    Choi, Jin Ho
    Hwang, Il Tae
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 356 - 356
  • [50] Long-term safety and effectiveness of recombinant human growth Hormone in Korean pediatric patients with growth disorders: 9-year interim analysis from LG Growth Study
    Kim, Yoo-Mi
    Chung, Sochung
    Rhie, Young-Jun
    Kim, Jae Hyun
    Chae, Hyun-Wook
    Choi, Jin Ho
    Lee, Young Ah
    Lee, Hae Sang
    Hwang, Il Tae
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 273 - 273